A shortage and user error are being blamed for a massive spike in calls to the Utah Poison Control Center over weight loss ...

Model Lottie Moss is speaking out against the use of diabetes medication for weight loss after she allegedly had a seizure ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

I hope that by talking about this, it can maybe be a lesson to some people that it’s not worth it.” The post Model Shares Warning After Overdose On Ozempic: “Worst Decision I Ever Made” first appeared ...

Semaglutide, available as Ozempic and Wegovy, has been hailed as a monumental breakthrough in the war on obesity. But there ...

The lower strengths of the jab Ozempic, which is licensed here for people with diabetes for blood sugar control, are at the centre of another supply problem. The 0.25 and 0.50 strengths have ...

Q: My doctor prescribed Ozempic for Type 2 diabetes. I got the dose up to 0.5 milligrams after several weeks. Then I began to ...

While Novo is struggling to keep up with demand for its obesity drugs, U.S. rival Eli Lilly sees supply restraints easing.

Investing.com -- The European market is facing shortages of Novo Nordisk's (NYSE:NVO) injectable glucagon-like peptide-1 receptor agonist (GLP-1 RA), Ozempic, a critical medication for managing type 2 ...

Update: Adds company statement about Ozempic availability in the U.S. Novo Nordisk (NVO) has said in a note published by the European Medicines Agency that the supply shortage of its diabetes drug ...